The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, February 24, 2020
Teva Respiratory announced the FDA has approved ArmonAir Digihaler Inhalation Powder, an inhaled corticosteroid delivered via Digihaler device for ...
read more
Tuesday, February 25, 2020
The FDA approved the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol.
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more
Wednesday, February 26, 2020
Perrigo and Catalent Pharma Solutions announced the FDA has approved Perrigo’s ANDA for generic albuterol sulfate inhalation aerosol.
read more
Thursday, February 27, 2020
Halozyme announced the FDA has accepted a BLA from Genentech for the fixed-dose combination of Perjeta and Herceptin for subcutaneous administration ...
read more
Thursday, February 27, 2020
Oramed announced positive topline data from the second and final cohort of its Phase 2b trial evaluating its lead oral insulin candidate, ORMD-0801, ...
read more
ANI received approval of the Company's ANDA from the FDA for Memantine Hydrochloride Extended-Release Capsules 7 mg, 14 mg, 21 mg and 28 mg.
read more
Hikma Pharmaceuticals USA is voluntarily extending its previously-announced recall of certain lots of Ketorolac Tromethamine Injection USP 30mg/mL, ...
read more
Mylan announced the launch of Wixela Inhub, the first available bioequivalent alternative to ADVAIR DISKUS in Canada.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
INTERPHEX announced the postponed events will take place on July 15-17, 2020 at the Javits Center in New York City.
read more
Catalent welcomed the announcement by Biohaven the FDA has approved its NURTEC™ ODT for acute migraine in adults.
read more
Inhaled Nitric Oxide is currently being tested in clinical trials as a potential treatment for patients infected with the Coronavirus.
read more
ANI has submitted a PAS to the Endocrinology Division at the FDA for re-commercialization of Purified Cortrophin Gel.
read more
The FDA is alerting patients, caregivers and health care professionals that EpiPen and EpiPen Jr auto-injectors, and authorized generic versions, may ...
read more